Clinical Trials
3 trialsNCT00748215 2020-12-02
Calcium Aluminosilicate Anti-Diarrheal in Treating and Preventing Diarrhea in Patients With Metastatic Colorectal Cancer Receiving Irinotecan
M.D. Anderson Cancer Center
Phase 2 Completed
NCT02018653 2018-07-26
CASAD for Severe Diarrhea in the Emergency Department
M.D. Anderson Cancer Center
Phase NA Terminated
NCT01739634 2012-12-03
The Efficacy of CASAD in Patients With Diarrhea Related to Medullary Thyroid Cancer
Salient Pharmaceuticals Incorporated
Phase 1/2 Unknown